| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.58 | 0.002 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.53 | 0.004 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |